1 Herceptin Biosimilar Market Overview 1.1 Herceptin Biosimilar Product Overview 1.2 Herceptin Biosimilar Market Segment by Type 1.2.1 Breast Cancer 1.2.2 Colorectal Cancer 1.2.3 Leukemia 1.2.4 Lymphoma 1.2.5 Other 1.3 Global Herceptin Biosimilar Market Size by Type (2015-2026) 1.3.1 Global Herceptin Biosimilar Market Size Overview by Type (2015-2026) 1.3.2 Global Herceptin Biosimilar Historic Market Size Review by Type (2015-2020) 1.3.2.1 Global Herceptin Biosimilar Sales Market Share Breakdown by Type (2015-2020) 1.3.2.2 Global Herceptin Biosimilar Revenue Market Share Breakdown by Type (2015-2020) 1.3.2.3 Global Herceptin Biosimilar Average Selling Price (ASP) by Type (2015-2020) 1.3.3 Global Herceptin Biosimilar Market Size Forecast by Type (2021-2026) 1.3.3.1 Global Herceptin Biosimilar Sales Market Share Breakdown by Type (2021-2026) 1.3.3.2 Global Herceptin Biosimilar Revenue Market Share Breakdown by Type (2021-2026) 1.3.3.3 Global Herceptin Biosimilar Average Selling Price (ASP) by Type (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America Herceptin Biosimilar Sales Breakdown by Type (2015-2020) 1.4.2 Europe Herceptin Biosimilar Sales Breakdown by Type (2015-2020) 1.4.3 Asia-Pacific Herceptin Biosimilar Sales Breakdown by Type (2015-2020) 1.4.4 Latin America Herceptin Biosimilar Sales Breakdown by Type (2015-2020) 1.4.5 Middle East and Africa Herceptin Biosimilar Sales Breakdown by Type (2015-2020) 2 Global Herceptin Biosimilar Market Competition by Company 2.1 Global Top Players by Herceptin Biosimilar Sales (2015-2020) 2.2 Global Top Players by Herceptin Biosimilar Revenue (2015-2020) 2.3 Global Top Players Herceptin Biosimilar Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers Herceptin Biosimilar Manufacturing Base Distribution, Sales Area, Product Type 2.5 Herceptin Biosimilar Market Competitive Situation and Trends 2.5.1 Herceptin Biosimilar Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by Herceptin Biosimilar Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2019) 2.7 Date of Key Manufacturers Enter into Herceptin Biosimilar Market 2.8 Key Manufacturers Herceptin Biosimilar Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global Herceptin Biosimilar by Region (2015-2026) 3.1 Global Herceptin Biosimilar Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global Herceptin Biosimilar Market Size Market Share by Region (2015-2020) 3.2.1 Global Herceptin Biosimilar Sales Market Share by Region (2015-2020) 3.2.2 Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020) 3.2.3 Global Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global Herceptin Biosimilar Market Size Market Share by Region (2021-2026) 3.3.1 Global Herceptin Biosimilar Sales Market Share by Region (2021-2026) 3.3.2 Global Herceptin Biosimilar Revenue Market Share by Region (2021-2026) 3.3.3 Global Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2021-2026) 4 Global Herceptin Biosimilar by Application 4.1 Herceptin Biosimilar Segment by Application 4.1.1 Hospital & Clinics 4.1.2 Oncology Centers 4.1.3 Other 4.2 Global Herceptin Biosimilar Sales by Application: 2015 VS 2020 VS 2026 4.3 Global Herceptin Biosimilar Historic Sales by Application (2015-2020) 4.4 Global Herceptin Biosimilar Forecasted Sales by Application (2021-2026) 4.5 Key Regions Herceptin Biosimilar Market Size by Application 4.5.1 North America Herceptin Biosimilar by Application 4.5.2 Europe Herceptin Biosimilar by Application 4.5.3 Asia-Pacific Herceptin Biosimilar by Application 4.5.4 Latin America Herceptin Biosimilar by Application 4.5.5 Middle East and Africa Herceptin Biosimilar by Application 5 North America Herceptin Biosimilar Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America Herceptin Biosimilar Sales Market Share by Country (2015-2020) 5.1.2 North America Herceptin Biosimilar Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America Herceptin Biosimilar Sales Market Share by Country (2021-2026) 5.2.2 North America Herceptin Biosimilar Revenue Market Share by Country (2021-2026) 6 Europe Herceptin Biosimilar Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe Herceptin Biosimilar Sales Market Share by Country (2015-2020) 6.1.2 Europe Herceptin Biosimilar Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe Herceptin Biosimilar Sales Market Share by Country (2021-2026) 6.2.2 Europe Herceptin Biosimilar Revenue Market Share by Country (2021-2026) 7 Asia-Pacific Herceptin Biosimilar Market Size by Region (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Region (2015-2020) 7.1.1 Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2015-2020) 7.1.2 Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Region (2021-2026) 7.2.1 Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2021-2026) 7.2.2 Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2021-2026) 8 Latin America Herceptin Biosimilar Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America Herceptin Biosimilar Sales Market Share by Country (2015-2020) 8.1.2 Latin America Herceptin Biosimilar Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America Herceptin Biosimilar Sales Market Share by Country (2021-2026) 8.2.2 Latin America Herceptin Biosimilar Revenue Market Share by Country (2021-2026) 9 Middle East and Africa Herceptin Biosimilar Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2021-2026) 10 Company Profiles and Key Figures in Herceptin Biosimilar Business 10.1 Amgen 10.1.1 Amgen Corporation Information 10.1.2 Amgen Description, Business Overview 10.1.3 Amgen Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.1.4 Amgen Herceptin Biosimilar Products Offered 10.1.5 Amgen Recent Developments 10.2 AryoGen Biopharma 10.2.1 AryoGen Biopharma Corporation Information 10.2.2 AryoGen Biopharma Description, Business Overview 10.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.2.4 Amgen Herceptin Biosimilar Products Offered 10.2.5 AryoGen Biopharma Recent Developments 10.3 Biocon 10.3.1 Biocon Corporation Information 10.3.2 Biocon Description, Business Overview 10.3.3 Biocon Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.3.4 Biocon Herceptin Biosimilar Products Offered 10.3.5 Biocon Recent Developments 10.4 Celltrion 10.4.1 Celltrion Corporation Information 10.4.2 Celltrion Description, Business Overview 10.4.3 Celltrion Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.4.4 Celltrion Herceptin Biosimilar Products Offered 10.4.5 Celltrion Recent Developments 10.5 Gedeon Richter 10.5.1 Gedeon Richter Corporation Information 10.5.2 Gedeon Richter Description, Business Overview 10.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.5.4 Gedeon Richter Herceptin Biosimilar Products Offered 10.5.5 Gedeon Richter Recent Developments 10.6 Genor Biopharma 10.6.1 Genor Biopharma Corporation Information 10.6.2 Genor Biopharma Description, Business Overview 10.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.6.4 Genor Biopharma Herceptin Biosimilar Products Offered 10.6.5 Genor Biopharma Recent Developments 10.7 Mabion 10.7.1 Mabion Corporation Information 10.7.2 Mabion Description, Business Overview 10.7.3 Mabion Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.7.4 Mabion Herceptin Biosimilar Products Offered 10.7.5 Mabion Recent Developments 10.8 Mylan 10.8.1 Mylan Corporation Information 10.8.2 Mylan Description, Business Overview 10.8.3 Mylan Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.8.4 Mylan Herceptin Biosimilar Products Offered 10.8.5 Mylan Recent Developments 10.9 Roche 10.9.1 Roche Corporation Information 10.9.2 Roche Description, Business Overview 10.9.3 Roche Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020) 10.9.4 Roche Herceptin Biosimilar Products Offered 10.9.5 Roche Recent Developments 10.10 The Instituto Vital Brazil 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Herceptin Biosimilar Product Category, Application and Specification 10.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020) 10.10.4 Main Business Overview 10.10.5 The Instituto Vital Brazil Recent Developments 11 Herceptin Biosimilar Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Herceptin Biosimilar Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Herceptin Biosimilar Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Herceptin Biosimilar Industry Trends 11.4.2 Herceptin Biosimilar Market Drivers 11.4.3 Herceptin Biosimilar Market Challenges 11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

List of Tables Table 1. Major Players of Breast Cancer Table 2. Major Players of Colorectal Cancer Table 3. Major Players of Leukemia Table 4. Major Players of Lymphoma Table 5. Major Players of Other Table 6. Global Herceptin Biosimilar Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million) Table 7. Global Herceptin Biosimilar Sales (K Units) by Type (2015-2020) (K Units) Table 8. Global Herceptin Biosimilar Sales Share by Type (2015-2020) Table 9. Global Herceptin Biosimilar Revenue (Million USD) by Type (2015-2020) Table 10. Global Herceptin Biosimilar Revenue Share by Type (2015-2020) Table 11. Global Herceptin Biosimilar Average Selling Price (ASP) (USD/Unit) by Type (2015-2020) Table 12. Global Herceptin Biosimilar Sales by Type (2021-2026) (K Units) Table 13. Global Herceptin Biosimilar Sales Share by Type (2021-2026) Table 14. Global Herceptin Biosimilar Revenue (US$ Million) by Type (2021-2026) Table 15. Global Herceptin Biosimilar Revenue Share by Type (2021-2026) Table 16. Global Herceptin Biosimilar Average Selling Price (ASP) (USD/Unit) by Type (2021-2026) Table 17. North America Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020) Table 18. Europe Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020) Table 19. Asia-Pacific Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020) Table 20. Latin America Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020) Table 21. Middle East and Africa Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020) Table 22. Global Herceptin Biosimilar Sales (K Units) by Company (2015-2020) Table 23. Global Herceptin Biosimilar Sales Share by Company (2015-2020) Table 24. Global Herceptin Biosimilar Revenue (Million US$) by Company (2015-2020) Table 25. Global Herceptin Biosimilar Revenue Share by Company (2015-2020) Table 26. Global Market Herceptin Biosimilar Average Selling Price (USD/Unit) by Company (2015-2020) Table 27. Global Herceptin Biosimilar Top Manufacturers Manufacturing Base Distribution and Sales Area Table 28. Global Herceptin Biosimilar Top Manufacturers Product Category Table 29. Global Herceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2019 Table 31. Date of Key Manufacturers Enter into Herceptin Biosimilar Market Table 32. Key Manufacturers Herceptin Biosimilar Product Type Table 33. Mergers & Acquisitions, Expansion Plans Table 34. Global Herceptin Biosimilar Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 Table 35. Global Herceptin Biosimilar Sales (K Units) by Region (2015-2020) Table 36. Global Herceptin Biosimilar Sales Market Share by Region (2015-2020) Table 37. Global Herceptin Biosimilar Revenue (US$ Million) by Region (2015-2020) Table 38. Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020) Table 39. Global Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 40. Global Herceptin Biosimilar Sales (K Units) by Region (2021-2026) Table 41. Global Herceptin Biosimilar Sales Market Share by Region (2021-2026) Table 42. Global Herceptin Biosimilar Revenue (US$ Million) by Region (2021-2026) Table 43. Global Herceptin Biosimilar Revenue Market Share by Region (2021-2026) Table 44. Global Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Herceptin Biosimilar Sales (K Units) by Application: 2015 VS 2020 VS 2026 Table 46. Global Herceptin Biosimilar Sales (K Units) by Application (2015-2020) Table 47. Global Herceptin Biosimilar Sales Share by Application (2015-2020) Table 48. Global Herceptin Biosimilar Sales (K Units) by Application (2021-2026) Table 49. Global Herceptin Biosimilar Sales Share by Application (2021-2026) Table 50. North America Herceptin Biosimilar Sales (K Units) by Application (2015-2020) Table 51. North America Sales Herceptin Biosimilar Market Share by Application (2015-2020) Table 52. Europe Herceptin Biosimilar Sales (K Units) by Application (2015-2020) Table 53. Europe Sales Herceptin Biosimilar Market Share by Application In 2019 Table 54. Asia-Pacific Herceptin Biosimilar Sales (K Units) by Application (2015-2020) Table 55. Asia-Pacific Sales Herceptin Biosimilar Market Share by Application In 2019 Table 56. Latin America Herceptin Biosimilar Sales (K Units) by Application (2015-2020) Table 57. Latin America Sales Herceptin Biosimilar Market Share by Application In 2019 Table 58. Middle East and Africa Herceptin Biosimilar Sales (K Units) by Application (2015-2020) Table 59. Middle East and Africa Herceptin Biosimilar Sales Share by Application (2015-2020) Table 60. North America Herceptin Biosimilar Sales (K Units) by Country (2015-2020) Table 61. North America Herceptin Biosimilar Sales Market Share by Country (2015-2020) Table 62. North America Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020) Table 63. North America Herceptin Biosimilar Revenue Market Share by Country (2015-2020) Table 64. North America Herceptin Biosimilar Sales (K Units) by Country (2021-2026) Table 65. North America Herceptin Biosimilar Sales Market Share by Country (2021-2026) Table 66. North America Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026) Table 67. North America Herceptin Biosimilar Revenue Market Share by Country (2021-2026) Table 68. Europe Herceptin Biosimilar Sales (K Units) by Country (2015-2020) Table 69. Europe Herceptin Biosimilar Sales Market Share by Country (2015-2020) Table 70. Europe Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020) Table 71. Europe Herceptin Biosimilar Revenue Market Share by Country (2015-2020) Table 72. Europe Herceptin Biosimilar Sales (K Units) by Country (2021-2026) Table 73. Europe Herceptin Biosimilar Sales Market Share by Country (2021-2026) Table 74. Europe Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026) Table 75. Europe Herceptin Biosimilar Revenue Market Share by Country (2021-2026) Table 76. Asia-Pacific Herceptin Biosimilar Sales (K Units) by Region (2015-2020) Table 77. Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2015-2020) Table 78. Asia-Pacific Herceptin Biosimilar Revenue (US$ Million) by Region (2015-2020) Table 79. Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2015-2020) Table 80. Asia-Pacific Herceptin Biosimilar Sales (K Units) by Region (2021-2026) Table 81. Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2021-2026) Table 82. Asia-Pacific Herceptin Biosimilar Revenue (US$ Million) by Region (2021-2026) Table 83. Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2021-2026) Table 84. Latin America Herceptin Biosimilar Sales (K Units) by Country (2015-2020) Table 85. Latin America Herceptin Biosimilar Sales Market Share by Country (2015-2020) Table 86. Latin America Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020) Table 87. Latin America Herceptin Biosimilar Revenue Market Share by Country (2015-2020) Table 88. Latin America Herceptin Biosimilar Sales (K Units) by Country (2021-2026) Table 89. Latin America Herceptin Biosimilar Sales Market Share by Country (2021-2026) Table 90. Latin America Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026) Table 91. Latin America Herceptin Biosimilar Revenue Market Share by Country (2021-2026) Table 92. Middle East and Africa Herceptin Biosimilar Sales (K Units) by Country (2015-2020) Table 93. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2015-2020) Table 94. Middle East and Africa Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020) Table 95. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2015-2020) Table 96. Middle East and Africa Herceptin Biosimilar Sales (K Units) by Country (2021-2026) Table 97. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2021-2026) Table 98. Middle East and Africa Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026) Table 99. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2021-2026) Table 100. Amgen Corporation Information Table 101. Amgen Description and Business Overview Table 102. Amgen Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Amgen Herceptin Biosimilar Product Table 104. Amgen Recent Developments Table 105. AryoGen Biopharma Corporation Information Table 106. AryoGen Biopharma Description and Business Overview Table 107. AryoGen Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. AryoGen Biopharma Herceptin Biosimilar Product Table 109. AryoGen Biopharma Recent Developments Table 110. Biocon Corporation Information Table 111. Biocon Description and Business Overview Table 112. Biocon Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 113. Biocon Herceptin Biosimilar Product Table 114. Biocon Recent Developments Table 115. Celltrion Corporation Information Table 116. Celltrion Description and Business Overview Table 117. Celltrion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 118. Celltrion Herceptin Biosimilar Product Table 119. Celltrion Recent Developments Table 120. Gedeon Richter Corporation Information Table 121. Gedeon Richter Description and Business Overview Table 122. Gedeon Richter Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Gedeon Richter Herceptin Biosimilar Product Table 124. Gedeon Richter Recent Developments Table 125. Genor Biopharma Corporation Information Table 126. Genor Biopharma Description and Business Overview Table 127. Genor Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. Genor Biopharma Herceptin Biosimilar Product Table 129. Genor Biopharma Recent Developments Table 130. Mabion Corporation Information Table 131. Mabion Description and Business Overview Table 132. Mabion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 133. Mabion Herceptin Biosimilar Product Table 134. Mabion Recent Developments Table 135. Mylan Corporation Information Table 136. Mylan Description and Business Overview Table 137. Mylan Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 138. Mylan Herceptin Biosimilar Product Table 139. Mylan Recent Developments Table 140. Roche Corporation Information Table 141. Roche Description and Business Overview Table 142. Roche Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 143. Roche Herceptin Biosimilar Product Table 144. Roche Recent Developments Table 145. The Instituto Vital Brazil Corporation Information Table 146. The Instituto Vital Brazil Description and Business Overview Table 147. The Instituto Vital Brazil Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 148. The Instituto Vital Brazil Herceptin Biosimilar Product Table 149. The Instituto Vital Brazil Recent Developments Table 150. Key Raw Materials Lists Table 151. Raw Materials Key Suppliers Lists Table 152. Herceptin Biosimilar Opportunities and Drivers Table 153. Herceptin Biosimilar Market Challenges Table 154. Herceptin Biosimilar Market Risks Table 155. Distributors List Table 156. Herceptin Biosimilar Downstream Customers Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Herceptin Biosimilar Product Picture Figure 2. Global Herceptin Biosimilar Market Size (Value), (illion USD), 2015 VS 2020 VS 2026 Figure 3. Global Herceptin Biosimilar Revenue (Million USD) Status and Outlook (2015-2026) Figure 4. Global Herceptin Biosimilar Sales (K Units) Status and Outlook (2015-2026) Figure 5. Product Picture of Breast Cancer Figure 6. Global Breast Cancer Sales (K Units): YoY Growth (2015-2020) Figure 7. Product Picture of Colorectal Cancer Figure 8. Global Colorectal Cancer Sales (K Units): YoY Growth (2015-2020) Figure 9. Product Picture of Leukemia Figure 10. Global Leukemia Sales (K Units): YoY Growth (2015-2020) Figure 11. Product Picture of Lymphoma Figure 12. Global Lymphoma Sales (K Units): YoY Growth (2015-2020) Figure 13. Product Picture of Other Figure 14. Global Other Sales (K Units): YoY Growth (2015-2020) Figure 15. Global Herceptin Biosimilar Revenue and Growth Rate by Type (US$ Million) (2015-2026) Figure 16. Global Herceptin Biosimilar Sales Market Share by Type in 2019 Figure 17. Global Herceptin Biosimilar Revenue Share by Type (2015-2020) Figure 18. Global Herceptin Biosimilar Revenue Market Share by Type in 2019 Figure 19. Global Herceptin Biosimilar Sales Market Share by Type (2021-2026) Figure 20. Global Herceptin Biosimilar Sales Market Share by Type In 2019 Figure 21. Global Herceptin Biosimilar Revenue Share by Type (2021-2026) Figure 22. Global Herceptin Biosimilar Revenue Market Share by Type In 2019 Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Herceptin Biosimilar Sales in 2019 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Herceptin Biosimilar Revenue in 2019 Figure 25. Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 27. Hospital & Clinics Examples Figure 28. Oncology Centers Examples Figure 29. Other Examples Figure 30. Key Raw Materials Price Figure 31. Herceptin Biosimilar Manufacturing Cost Structure Figure 32. Herceptin Biosimilar Industrial Chain Analysis Figure 33. Porter's Five Forces Analysis Figure 34. Channels of Distribution Figure 35. Distributors Profiles Figure 36. Bottom-up and Top-down Approaches for This Report Figure 37. Data Triangulation Figure 38. Key Executives Interviewed

Amgen AryoGen Biopharma Biocon Celltrion Gedeon Richter Genor Biopharma Mabion Mylan Roche The Instituto Vital Brazil